Aesica and partners receive METRC Innovation Award

Published: 18-Dec-2012
Manufacturing Ingredients

Collaborates with Durham and Leeds Universities to commercialise new manufacturing technology


Aesica, the University of Durham and the University of Leeds have been awarded a METRC Innovation Award, which will be used to develop processes that will improve cost efficiencies and increase manufacturing capacity at the UK contract manufacturing organisation’s Cramlington site.

Earlier this year, the company established the Aesica Innovation Board (AIB) to identify and commercialise new technologies that would help to bridge the growing R&D gap and the company is actively seeking development partnerships with academia and innovative businesses.

This latest partnership builds on a collaboration formed with Bradford University this year. It aims to develop new or improved routes for the manufacture of an API. A detailed kinetic study is already underway and based on this new flow processes will be developed before being scaled up at Cramlington.

  • Companies:
  • Aesica Pharmaceuticals
See more

You may also like

Manufacturing

Aesica to exhibit at CPhI Worldwide 2017

Read more
Aesica is a leading pharmaceutical contract development and manufacturing organisation for both API and finished dose forms

Trending Articles

  1. Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes
  2. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  3. Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio
  4. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  5. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Manufacturing

Aesica to exhibit at CPhI Worldwide 2017

Aesica is a leading pharmaceutical contract development and manufacturing organisation for both API and finished dose forms
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

How contract manufacturers can bridge the innovation–commercialisation divide

With R&D budgets under pressure, the pharmaceutical industry would do well to look to the contract manufacturing sector for innovative approaches and technologies that could make production more effective and efficient, and achieve more with finite resources
Manufacturing

Aesica Pharmaceuticals implements Ci-DMS Weigh and Dispense from CI Precision

Analysis demonstrated that the MES Weigh and Dispense and SAP Interface modules would mitigate the risk of human error
Manufacturing

Aesica adds development capability at Queenborough plant in Kent

Opens new purpose-built facility and expands services for highly potent and controlled drugs
Design & Build

Aesica relocates development and clinical manufacturing services from Nottingham to Queenborough, Kent

Offers double the capacity of the existing development centre
Manufacturing

Bespak and Aesica unveil new single source supply chain solution for drug delivery manufacturing services

Set to streamline and speed products to market while reducing cost and complexity of development
Manufacturing

LIVE FROM CPHI: Aesica introduces new supply chain service model

And outlines its plans for the future with sister company medical device manufacturer Bespak
Subscribe now